Moleculin Biotech is trading at $1.24 (10.3% down) as the stock continues to face selling pressure following a significant decline in the previous session.
- The move follows a steep 37.9% drop yesterday, which saw the share price tumble from $2.19 to $1.36.
- No fresh company-specific news, regulatory filings, or analyst updates have been released to explain the continued downward momentum.
- With the broader market trending higher today, the price action suggests weak investor sentiment and technical follow-through rather than a new event-driven reaction.